A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

NCT01920737 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Daunorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: PEG-Asparaginase
DRUG: Methotrexate
DRUG: 6-MP (6-Mercaptopurine)
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Leucovorin
DRUG: Dexamethasone
OTHER: Blood draw
DEVICE: CT/PET scans

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]